CRWV insider filing: 3,000,000 founder shares to be sold via Goldman Sachs

Rhea-AI Filing Summary

CoreWeave (CRWV) filed a Form 144 reporting a proposed sale of 3,000,000 shares of common stock through Goldman Sachs & Co. LLC on 08/14/2025, with an aggregate market value of $298,515,000. The filing shows these shares were acquired as founder shares on 09/21/2017 and total outstanding shares are reported as 370,470,348, so the proposed sale represents roughly 0.8% of outstanding stock. The notice also discloses two recent sales during the same date by related trusts totaling 240,000 shares for aggregate gross proceeds of $21,732,000. The signer certifies no undisclosed material adverse information and references Rule 10b5-1 trading plan conditions where applicable.

Positive

• Transparency: The filing identifies broker, sale date, share count, acquisition history, and recent related sales, meeting disclosure requirements.

Negative

• Significant insider sale: Proposed sale of 3,000,000 shares valued at $298,515,000 could increase share supply around the sale date.

Insights

Financial Analyst

TL;DR: A founder-linked block of 3,000,000 shares is being registered for sale, representing ~0.8% of float and valued at $298.5M.

The filing is a routine insider liquidity notice rather than an operational disclosure. Key investor implications are liquidity-driven: the size and value of the sale could increase share supply near the sale date but does not on its face indicate company performance issues. The shares were acquired in 2017 as founder shares, suggesting long-held positions being monetized. Recent smaller trust sales totaling 240,000 shares for $21.7M confirm concurrent insider selling activity.

Corporate Governance Expert

TL;DR: The Form 144 is a standard compliance filing; signer affirms no undisclosed material information and cautions on 10b5-1 plan disclosure.

The document meets disclosure requirements by identifying broker, sale date, share counts, acquisition history, and recent related sales. The explicit certification about material adverse information and mention of trading-plan adoption dates (if applicable) align with governance best practices. There is no indication of unusual procedural issues in the filing itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	3000000	298515000	370470348	08/14/2025	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/21/2017	Founder Shares	The Issuer			2556000	09/21/2017	None
Common Stock	09/21/2017	Founder Shares	The Issuer			111000	09/21/2017	None
Common Stock	09/21/2017	Founder Shares	The Issuer			111000	09/21/2017	None
Common Stock	09/21/2017	Founder Shares	The Issuer			111000	09/21/2017	None
Common Stock	09/21/2017	Founder Shares	The Issuer			111000	09/21/2017	None

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Coconut Tree Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	120000	10866000
Apple Tree Trust 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common Stock	08/14/2025	120000	10866000

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CoreWeave (CRWV) announce?

It notifies of a proposed sale of 3,000,000 common shares through Goldman Sachs on 08/14/2025 with an aggregate market value of $298,515,000.

How much of CoreWeave's outstanding stock does the sale represent?

The filing lists 370,470,348 shares outstanding, so 3,000,000 shares represent roughly 0.8% of outstanding shares.

When and how were the shares being sold acquired?

All 3,000,000 shares were acquired as founder shares on 09/21/2017 from the issuer, with no cash payment indicated for those founder shares.

Were there any recent related sales disclosed?

Yes. Two trusts sold 120,000 shares each on 08/14/2025, generating gross proceeds of $10,866,000 each (total $21,732,000).

Does the filing indicate any undisclosed material information about CoreWeave?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.